about
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.Hyperhomocysteinemia and mortality after coronary artery bypass graftingGene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseRelationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAIDs hypersensitivitySequence variants affecting eosinophil numbers associate with asthma and myocardial infarctionAccess rate to the emergency department for venous thromboembolism in relationship with coarse and fine particulate matter air pollutionGenome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysmIdentification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesLarge-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyExome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.Loss-of-function mutations in APOC3, triglycerides, and coronary diseaseAssociation of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacksLack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studiesCombined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.Hepcidin levels and their determinants in different types of myelodysplastic syndromes.A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene.Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study.Paraoxonase-1 status in patients with hereditary hemochromatosisCoding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.Reduced serum hepcidin levels in patients with chronic hepatitis C.A 'desaturase hypothesis' for atherosclerosis: Janus-faced enzymes in omega-6 and omega-3 polyunsaturated fatty acid metabolism.Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.Iron deficiency in the elderly population, revisited in the hepcidin era.Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease.Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.Evaluation of finger skin temperature in scleroderma patients cyclically treated with iloprost.Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.Multi-allelic haplotype association identifies novel information different from single-SNP analysis: a new protective haplotype in the LRP8 gene is against familial and early-onset CAD and MI.Monosodium benzoate hypersensitivity in subjects with persistent rhinitis.Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study.Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile.Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.
P50
Q24645076-4BC48090-400B-43B8-8B46-5EB5ABB1D8DFQ28213269-2D8B8FC2-8D77-482A-ACA1-6D9E28347B26Q28221103-4BDBBE4F-C6E8-462D-AD9A-0E98C7C7D21CQ28221753-71FD7E38-94F5-49F7-A852-6A1097E862FBQ28308221-597349CC-7033-43D7-81D8-4B4C5EB4F138Q28730637-F03CFD76-9CC7-4CED-A21D-537C1690D5B8Q28943557-9E9134CF-74B9-49D0-BA3A-3093E101FEACQ29417010-9EB24E8A-1202-484F-853E-A52996D48911Q29417023-6237C6E4-6F31-4E4A-BBA0-FF2D607AE038Q29615729-A28F1C3F-B186-412C-A0AF-54047B0ECDE9Q30301147-F6E961E6-27BE-4300-8F23-B0F6A137AA35Q30408720-1A1B0ECA-659D-4B0A-AC30-56CDCC84FAD8Q30411387-F77B4B7A-0C6F-48E2-A6CB-AAB74D4EE297Q30499949-A10653E5-9919-4F25-B278-41A1416C9B82Q33318443-BCB7742E-6803-4B43-8D57-D6FA2B5EB232Q33445395-E665FA97-2358-4F36-AFAA-D1A52352312CQ33802213-3A8CBE01-88BB-40B2-800C-98ADC28CFDDEQ34008796-E196E94B-E67A-4B23-B0C5-D6BAAD56BB5AQ34076234-AAE9477E-9DFE-4BAB-981F-802AF49F1E15Q35231847-EDCFEE85-5218-4CBA-9B4B-A687AE2F6CC4Q35609284-30F402D0-19B0-45A3-B93A-7C573882B0D6Q36353620-153696CD-4CA2-4001-BA5D-EC6C41374086Q36431697-A13E9EB4-0A7B-4F28-A857-78E9553B9ED1Q36754854-1E5F5C94-3BCA-4963-9499-3EFAC1944BB0Q36851336-5ACA4EF5-4CC1-4C6C-8968-01E88C0D098CQ37387659-6BA45566-B977-4934-BA88-EAF216316F20Q37602474-EA47F8D3-1C43-4F00-B82F-1671A2A31B04Q37727765-D4259BAC-F2FC-461C-ABF6-4F6116B72CC7Q37734983-C52E6095-846D-41B1-BF39-77DB0D587230Q38086552-8336579E-2BED-4171-9C95-256EEA1B7FB0Q38388418-C6374A2F-6D4B-4D50-B9AB-E55D78597CC4Q39734548-462D71AF-A646-4A99-8BEA-4213AFECF707Q40809666-8F0741DB-ED57-41C1-95FD-583DC5D86BDDQ41941614-3E82DB79-FDD4-4D08-B962-56C9BF290D16Q42619131-216EBF19-87EC-4C1D-B96B-662558853105Q43114166-F8BFB227-C570-4BCA-954D-42F0307FF10DQ43225362-324234C1-6833-4596-ABA2-17816CD7D640Q43676503-0747E40C-0E3C-47C9-ACE2-85C88BF3EA7DQ44111577-C8D893E8-C2C9-4BC9-9DBC-6BA1B999211EQ44764577-7261ECB0-06E4-4637-B145-8D19275B1B14
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicola Martinelli
@ast
Nicola Martinelli
@en
Nicola Martinelli
@es
Nicola Martinelli
@nl
Nicola Martinelli
@sl
type
label
Nicola Martinelli
@ast
Nicola Martinelli
@en
Nicola Martinelli
@es
Nicola Martinelli
@nl
Nicola Martinelli
@sl
prefLabel
Nicola Martinelli
@ast
Nicola Martinelli
@en
Nicola Martinelli
@es
Nicola Martinelli
@nl
Nicola Martinelli
@sl
P1053
J-5622-2016
P106
P1153
6603750459
P21
P2798
P31
P3829
P496
0000-0001-6465-5119